Drug-Coated Balloons Versus Drug-Eluting Stents or Plain Old Balloon Angioplasty: A Long-Term in-Stent Restenosis Study
SCAAR registry demonstrated that treatment with drug-coated balloons (DCB) for coronary in-stent restenosis lesions was associated with lower risks of TLR, all-cause mortality, and cardiovascular death over 5 years compared to standard balloon angioplasty, but a higher rate of TLR compared to DES, Dr. Sacharias von Koch and colleagues, Clinical Sciences Lund University, Sweden, reported in the December 3 issue of the Journal of the American Heart Association.
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
